Results 121 to 130 of about 2,071 (187)

Supplementary Figure S3 from CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis

<p>Supplementary Figure S3</p>
Haichuan Wang, Yong Zeng, Jiwei Huang, Hongyu Zhou, Rui Xie, Lin Xu, Xuping Feng, Zheng Zhang, Zeyuan Qiang, Haotian Liao, Guoteng Qiu, Xiangzheng Chen, Shuai Xue   +12 more
openaire   +1 more source

Supplementary Figure S4 from CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis

<p>Supplementary Figure S4</p>
Haichuan Wang, Yong Zeng, Jiwei Huang, Hongyu Zhou, Rui Xie, Lin Xu, Xuping Feng, Zheng Zhang, Zeyuan Qiang, Haotian Liao, Guoteng Qiu, Xiangzheng Chen, Shuai Xue   +12 more
openaire   +1 more source

Supplementary Figure S22 from CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis

<p>Supplementary Figure S22</p>
Haichuan Wang, Yong Zeng, Jiwei Huang, Hongyu Zhou, Rui Xie, Lin Xu, Xuping Feng, Zheng Zhang, Zeyuan Qiang, Haotian Liao, Guoteng Qiu, Xiangzheng Chen, Shuai Xue   +12 more
openaire   +1 more source

CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer. [PDF]

Cancer Immunol Res
Li P, Xie Y, Zhou D, Li X, Liu Q, Li Z, Liu X, Lin J, Huang M, Yan Q, Luo Y, Yu H, Wang X.   +12 more
europepmc   +1 more source

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching. [PDF]

Protein Cell
Liu C, Xu F, Wu Y, Li J, Ni M, Xia S, Chen L, Zhao H, Yu M, Zhou Y, Zhang M, Li J, Wu X, Huang Y, Zhu T, Chen X.   +15 more
europepmc   +1 more source

Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate <i>CLK1</i> exon 4. [PDF]

Neurooncol Pediatr
Naqvi AS, Sullivan PJ, Corbett RJ, Sehgal P, Conkrite KL, Rathi KS, Ennis BM, Hayer KE, Zhang B, Brown MA, Miller DP, Sickler A, Kraya AA, Coleman KL, Dybas JM, Geng Z, Blackden C, Arif S, Chroni A, Lahiri A, Hollawell ML, Storm PB, Haydar D, Foster JB, Koptyra M, Madsen PJ, Diskin SJ, Thomas-Tikhonenko A, Resnick AC, Rokita JL.   +29 more
europepmc   +1 more source

Decoding SR protein regulation: kinases, phosphatases, and therapeutic targeting strategies. [PDF]

Cell Oncol (Dordr)
Liu N, van der Ende F, van de Water B, Le Dévédec SE.   +3 more
europepmc   +1 more source

Targeting the splice factor kinases SRPK1 and CLK1 in leukaemia

This study was aimed at investigating the effect of inhibiting SRPK1 in leukaemic cells. It was also aimed at exploring the potential utility of combining conventional leukaemia chemotherapy (such as imatinib) with compounds that inhibit SRPK1.SRPK1 is best known for its role in the phosphorylation of serine/argenine rich proteins (SR-proteins) which ...
openaire  

Phylogenetic and structural analyses reveal Cdc2-like kinases (CLKs) as ancient regulators of thermosensitive splicing. [PDF]

J Biol Chem
Ogle RA, Netherton JK, Robinson BR, Heyd F, Baker MA.   +4 more
europepmc   +1 more source

FeaSion decodes the regulatory landscape and functional diversity of RNA polymerase II CTD phosphorylation. [PDF]

Sci Adv
Zhu J, Bao L, Xu S, Ji X.
europepmc   +1 more source